Monitoring of Blood-¹⁰B Concentration for Boron Neutron Capture Therapy Using Prompt Gamma-Ray Analysis

References

• Allen B J, Moore D E, Harrington B V. Progress in neutron capture therapy for cancer. Plenum Press, New York 1992
   Google Scholar
• Barth R F, Soloway A H, Fairchild R G, Brugger R M. Boron neutron capture therapy for cancer. Cancer 1992; 70: 2995–3007
   PubMed Web of Science ®Google Scholar
• Dewit L, Moss R, Gabel D. New developments in neutron capture therapy. Eur J Cancer 1990; 26: 912–4
   PubMed Web of Science ®Google Scholar
• Hatanaka H, Sano K, Yasukochi H. Clinical results of boron neutron capture therapy. Progress in neutron capture therapy for cancer, B J Allen, D E Moore, B V Harrington. Plenum Press, New York 1992; 561–8
   Google Scholar
• Moss R L. Current overview of the approach of clinical trials at Petten. Boron neutron capture therapy; Toward clinical trials of glioma treatment, D Gabel, R L Moss. Plenum Press, New York 1992; 33–46
   Google Scholar
• Philipp K, Gavin P, Casado J, Siefert A, Moss R, Huiskamp R. Developments in healthy tissue tolerance studies as a precondition for clinical application of boron neutron capture therapy. Advances in neutron capture therapy, A H Soloway, R F Barth, D E Carpenter. Plenum Press, New York 1993; 571–4
   Google Scholar
• Fankhauser H, Stragliotto G, Zbinden P. Borocaptate sodium (BSH) pharmacokinetics in glioma patients. Boron neutron capture therapy; Toward clinical trials of glioma treatment, D Gabel, R L Moss. Plenum Press, New York 1992; 155–62
   Google Scholar
• Gavin P R, Kraft S L, DeHaan C E, Griebenow M L, Moore M P. A large animal model for boron neutron capture therapy. Progress in neutron capture therapy for cancer, B J Allen, D E Moore, B V Harrington. Plenum Press, New York 1992; 479–84
   Google Scholar
• Kraft S L, Gavin P R, DeHaan C E, et al. Borocaptate sodium: A potential boron delivery compound for boron neutron capture therapy evaluated in dogs with spontaneous intracranial tumors. Proc Natl Acad Sci USA 1992; 89: 11973–7
   PubMed Web of Science ®Google Scholar
• Slatkin D, Micca P, Forman A, Gabel D, Wielopolski L, Fairchild R. Boron uptake in melanoma, cerebrum and blood from Na2B12H11SH and Na4B24H22S2 administered to mice. Biochem Pharmacol 1986; 35: 1771–6
   PubMed Web of Science ®Google Scholar
• Haritz D, Gabel D, Huiskamp R. Clinical phase-I study of Na2B12H11SH (BSH) in patients with malignant glioma as precondition for boron neutron capture therapy (BNCT). Int J Radiat Oncol Biol Phys 1994; 28: 1175–81
   PubMed Web of Science ®Google Scholar
• Slatkin D N, Stoner R D, Rosander K M, Kalef-Ezra J A, Laissue J A. Central nervous system radiation syndrome in mice from preferential 10B(n, α)7Li irradiation of brain vasculature. Proc Natl Acad Sci USA 1988; 85: 4020–4
   PubMed Web of Science ®Google Scholar
• Barth R F, Adams D M, Soloway A H, Mechetner E B, Alam F, Anisuzzaman A KM. Determination of boron in tissues and cells using direct-current plasma atomic emission spectroscopy. Anal Chem 1991; 63: 890–3
   PubMed Web of Science ®Google Scholar
• Tamat S R, Moore D E, Allen B J. Determination of boron in biological tissues by inductively coupled plasma atomic emission spectrometry. Anal Chem 1987; 59: 2161–4
   PubMed Web of Science ®Google Scholar
• Fairchild R G, Gabel D, Laster B H, Greenberg D, Kiszenick W, Micca P L. Microanalytical techniques for boron analysis using the 10B(n, α)7Li reaction. Med Phys 1986; 13: 50–6
   PubMed Web of Science ®Google Scholar
• Gabel D, Holstein H, Larsson B, et al. Quantitative neutron capture radiography for studying the biodistribution of tumor-seeking boron-containing compounds. Cancer Res 1987; 47: 5451–4
   PubMed Web of Science ®Google Scholar
• Konijnenberg M W, Raaijmakers C PJ, Constantine G, . Prompt gamma-ray analysis to determine 10B concentrations. Advances in neutron capture therapy, A H Soloway, R F Barth, D E Carpenter, et al. Plenum Press, New York 1993; 419–22
   Google Scholar
• Kobayashi T, Kanda K. Microanalysis system of ppm-order 10B concentrations in tissue for neutron capture therapy by prompt gamma-ray spectrometry. Nucl Instrum Meth 1983; 204: 525–31
   Web of Science ®Google Scholar
• Bauer W F, Micca P L, White B M. A rapid method for the direct analysis of boron in whole blood by atomic emission spectroscopy. Advances in neutron capture therapy, A H Soloway, R F Barth, D E Carpenter. Plenum Press, New York 1993; 403–7
   Google Scholar
• Konijnenberg M W, Stecher-Rasmussen F, Raaijmakers C PJ, . Boron concentration measurements for the Petten BNCT project. Progress in neutron capture therapy for cancer, B J Allen, D E Moore, B V Harrington, et al. Plenum Press, New York 1992; 293–6
   Google Scholar
• Gregoire V, Begg A C, Huiskamp R, Verrijk R, Bartelink H. Selectivity of boron carriers for boron neutron capture therapy: pharmacological studies with borocaptate sodium, L-boronophenylalanine and boric acid in murine tumors. Radiother Oncol 1993; 27: 46–54
   PubMed Web of Science ®Google Scholar
• Gavin P R, Kraft S L, DeHaan C E, Swartz C D, Griebenow M L. Large animal normal tissue tolerance with boron neutron capture. Int J Radiat Oncol Biol Phys 1994; 28: 1099–106
   PubMed Web of Science ®Google Scholar
• Philipp K H, Huiskamp R, Casado J, Siefert A, Moss R L. Healthy tissue tolerance studies in dogs after boron neutron capture therapy. Proceedings of the CLINCT BNCT Workshop, I Auterinen, M Kallio. Helsinki 1994; 94–6, Helsinki University of Technology Report TKK-F-A718
   Google Scholar
• Gavin P R, Kraft S L, Wendling L R, Miller D L. Canine spontaneous brain tumours-a large animal study for BNCT. Strahlenther Onkol 1989; 65: 225–8
   Google Scholar